Dr. Agarwal’s Health Care IPO Review, Analysis, Good or Bad

As an investor, deciding whether the IPO is Good or Bad to invest in can often be challenging. If you are confused and worried about whether to Apply or Not Dr. Agarwal’s Health Care IPO. Then worry not here we are describing 10 important key points & in-depth detailed Dr. Agarwal’s Health Care IPO review which will help you to make the decision.

Strengths and Weaknesses of Dr. Agarwal’s Health Care IPO

Strengths:

• Over the years, the company has established itself as a trusted brand in the field of providing high-quality eye-care-related products and services.
• The company has shown a proven track record of providing organic growth, scaling acquisitions, and enhancing profitability.
• Dr. Agarwal’s health care offers a comprehensive range of eye care products and services.
• The company has generated a good return on equity (ROE) track record, for the past 3 years, the company has achieved an ROE of 36.1% respectively.

Weaknesses:

• Most of their income is generated from surgeries resulting in a significant growth of the company, any change in the income might majorly affect the financial growth and condition of the business.
• They are a renowned company due to their brand equity and reputation. If they fail to maintain that reputation properly due to negative publicity, it can also majorly affect their business, reputation, and financial growth.
• The company is dependent on retainership arrangements with doctors. Failing to attract or keep the doctors to leave before the agreements can majorly affect the business’s growth, finances, and business condition.
• Their international projects mostly subject them to legal, tax, political, and economic risks, not being able to address these issues can adversely affect their financial growth and business.

Dr. Agarwal’s Health Care IPO Details

1. Dr. Agarwal’s Health Care IPO Open and closing date?

The opening date of Dr. Agarwal’s Health Care IPO is on January 29, 2025, and the closing date of the IPO is on January 31, 2025.

2. What is the size of Dr. Agarwal’s Health Care  IPO?

The company planned to raise funds around ₹3,027.26 crores via IPO. This IPO consists of both components fresh issues of ₹300.00 crores and an offer for sale of up to 2,727.26 equity shares with a face value of ₹1 each.

3. What are the subscription details of Dr. Agarwal’s Health Care IPO?

Dr. Agarwal’s Health Care IPO price range is set at ₹382 to ₹402 per share. In this IPO a total of 35 shares were available in 1 lot size for the minimum Retail category and for the maximum retail category, 490 shares in 13 lot sizes were available, for the S-HNI Minimum category 525 shares were available in the 14 lot sizes. While for the B-HNI Minimum category 2,520 shares were available in 68 lot sizes.

To invest in this IPO, each investor category has specific investment amounts:

• Retail Investors: Minimum investment of ₹14,070 and maximum investment of ₹1,96,980.
• Small HNI (S-HNI): Minimum investment of ₹2,11,050.
• Big HNI (S-HNI): A minimum investment of ₹10,13,040 is required.

4. What is Dr. Agarwal’s Health Care IPO listing Date?

Dr. Agarwal’s Health Care is a Mainboard IPO whose shares will be listed on February 5, 2025, on the BSE (Bombay Stock Exchange) & NSE (National Stock Exchange).

5. What are the objectives of Dr. Agarwal’s Health Care IPO Issue?

One of the main objectives of raising funds via IPO is to utilize the proceeds for the repayment, and prepayment, in part or full, of the existing borrowings. The remaining funds will be used to support the general corporate purposes of the company.

6. About Dr. Agarwal’s Health Care  

One of the growing companies in the sector of providing eye care-related pharmaceutical products, Dr. Agarwal’s Health Care Limited, was founded in 2010. They offer a comprehensive range of products and eye care services such as cataract, refractive, surgeries, consultations, diagnoses, non-surgical treatments, opticals, contact lenses, and many other accessories. Because of its exceptional operational history, they are renowned for satisfying the customer’s needs by providing them with exceptional services in their eye-care-related journey. As of March 31, 2024, along with an India presence, the company has also established an international presence by building 15 facilities in 9 countries in Africa.

7. Dr. Agarwal’s Health Care IPO Financials

The company reported revenue of ₹1,376.45 crores in 2024 against ₹1,031.49 crores in 2023. The company reported a profit of ₹95.05 crores in 2024 against a Profit of ₹103.23 crores in 2023.

8. Dr. Agarwal’s Health Care IPO Promoters

Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr. Adil Agarwal, Dr. Anosh Agarwal, Dr Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal Family Trust, D.r Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, D.r Ashvin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust, Dr. Agarwal’s Eye Institute and Dr Agarwal’s Eye Institute Private Limited are some of the well-known promoters of the company.

9. Who are Dr. Agarwal’s Health Care IPO lead managers and registrar?

Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, and Motilal Oswal Investment Advisors Limited are the lead managers of Dr. Agarwal’s Health Care while KFin Technologies Limited is the registrar of the company.

10. Should you Apply or not for Dr. Agarwal’s Health Care IPO?

Dr. Agarwal’s Health Care is one of the growing companies in the eye care-related sector known for its reliability and presenting an attractive investment opportunity to invest in this IPO. As of March 31, 2024, among peers, the company is renowned for having the largest eye care facilities in India. They offer a comprehensive range of products and services related to eye care showing incredible growth potential of their company. The company consists of around 180 Facilities. In the year 2024, 667 doctors have helped treat 2.13 million patients, while 220,523 surgeries have been performed. They have categorized their facilities into three parts: Primary facilities, Secondary facilities, and Tertiary facilities.

So, now the question is should you apply or not for Dr. Agarwal’s Health Care IPO? Dr. Agarwal’s Health Care has shown incredible growth by generating a revenue of ₹11,617.71 Million from operations in India while generating a revenue of ₹1,703.81 Million outside India in the FY of 2024. While they have generated an Income of ₹8,551.86 million from surgeries in 2024. The incredible combination of solid financial, and well-defined growth strategy in eye-care-related products and services make Dr. Agarwal’s Health Care an attractive choice for investors to invest in. However, at the end of the day it is your choice to first check if this IPO is good or bad or whether you should apply or not by checking the company’s financial growth and potential to avoid any loss of the money. For more information and queries please connect with our IPOWatch team, we are always ready to help and solve your queries.